A detailed history of Commerce Bank transactions in Incyte Corp stock. As of the latest transaction made, Commerce Bank holds 9,221 shares of INCY stock, worth $699,597. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9,221
Holding current value
$699,597
% of portfolio
0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$57.33 - $68.61 $528,639 - $632,652
9,221 New
9,221 $609,000
Q1 2023

May 04, 2023

BUY
$70.23 - $86.01 $9,200 - $11,267
131 Added 4.69%
2,926 $211,000
Q4 2022

Feb 10, 2023

BUY
$67.18 - $84.11 $187,768 - $235,087
2,795 New
2,795 $224,000
Q2 2022

Aug 12, 2022

SELL
$66.18 - $83.18 $15,486 - $19,464
-234 Reduced 7.11%
3,055 $232,000
Q1 2022

May 09, 2022

BUY
$66.02 - $79.71 $10,233 - $12,355
155 Added 4.95%
3,289 $261,000
Q4 2021

Feb 14, 2022

BUY
$63.34 - $74.11 $198,507 - $232,260
3,134 New
3,134 $230,000
Q3 2021

Nov 09, 2021

SELL
$68.67 - $84.02 $483,848 - $592,004
-7,046 Closed
0 $0
Q2 2021

Aug 09, 2021

BUY
$79.87 - $87.53 $25,877 - $28,359
324 Added 4.82%
7,046 $593,000
Q1 2021

May 05, 2021

BUY
$76.02 - $100.5 $19,309 - $25,527
254 Added 3.93%
6,722 $546,000
Q4 2020

Feb 09, 2021

BUY
$80.74 - $97.7 $181,342 - $219,434
2,246 Added 53.2%
6,468 $563,000
Q3 2020

Nov 06, 2020

BUY
$85.07 - $109.69 $4,763 - $6,142
56 Added 1.34%
4,222 $379,000
Q2 2020

Aug 07, 2020

SELL
$74.18 - $108.93 $132,040 - $193,895
-1,780 Reduced 29.94%
4,166 $433,000
Q1 2020

May 08, 2020

BUY
$63.18 - $85.97 $139,754 - $190,165
2,212 Added 59.24%
5,946 $435,000
Q4 2019

Feb 14, 2020

BUY
$73.04 - $95.72 $40,391 - $52,933
553 Added 17.38%
3,734 $326,000
Q3 2019

Nov 12, 2019

BUY
$72.82 - $86.52 $9,830 - $11,680
135 Added 4.43%
3,181 $236,000
Q2 2019

Aug 07, 2019

BUY
$73.52 - $88.7 $42,200 - $50,913
574 Added 23.22%
3,046 $258,000
Q1 2019

May 08, 2019

BUY
$63.56 - $88.17 $157,120 - $217,956
2,472 New
2,472 $213,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16.9B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Commerce Bank Portfolio

Follow Commerce Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commerce Bank, based on Form 13F filings with the SEC.

News

Stay updated on Commerce Bank with notifications on news.